首页> 外文OA文献 >EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

【2h】

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

机译：EGFR介导的MAPK信号的再激活有助于BRAF-突变结直肠癌与vemureafenib的RAF抑制的不敏感性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ryan B. Corcoran; Hiromichi Ebi; Alexa B. Turke; Erin M. Coffee; Michiya Nishino; Alexandria P. Cogdill; Ronald D. Brown; Patricia Della Pelle; Dora Dias-Santagata; Kenneth E. Hung; Keith T. Flaherty; Adriano Piris; Jennifer A. Wargo; Jeffrey Settleman; Mari Mino-Kenudson; Jeffrey A. Engelman;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. FGFR-mediated reactivation of ERK signaling contributes to insensitivity of head and neck squamous cancer to MEK inhibition [J] . Yang Y. J., Na H. J., Ban M. J., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：FGFR介导的ERK信号传导重新激活导致头颈鳞癌对MEK抑制不敏感
2. c-Met-Mediated Reactivation of PI3K/AKT Signaling Contributes to Insensitivity of BRAF(V600E) Mutant Thyroid Cancer to BRAF Inhibition [J] . Byeon Hyung Kwon, Na Hwi Jung, Yang Yeon Ju, Molecular Carcinogenesis . 2016,第11期

机译：PI3K / AKT信号的c-Met介导的激活有助于BRAF（V600E）突变型甲状腺癌对BRAF抑制的不敏感性
3. FGFR-mediated reactivation of ERK signaling contributes to insensitivity of head and neck squamous cancer to MEK inhibition [J] . Yang Y. J., Na H. J., Ban M. J., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：FGFR介导的ERK信号的再激活有助于对MEK抑制的头部和颈部鳞癌的不敏感性
4. SWATH profiling of MAPK pathway mutant cancer cell lines reveals similarities in response to drug inhibition independent of cell type [C] . Christoph Krisp, Robert Parker, Matthew J. McKay, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：MAPK途径突变体癌细胞系的SWATH分析揭示了与细胞类型无关的药物抑制的相似性
5. Targeting Ras and Rho family GTPases for the treatment of cancer through inhibition of CAAX-signaled modifications and the ERK MAPK pathway. [D] . Roberts, Patrick J. 2007

机译：通过抑制CAAX信号修饰和ERK MAPK途径，靶向Ras和Rho家族GTPases治疗癌症。
6. EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib [O] . Ryan B. Corcoran, Hiromichi Ebi, Alexa B. Turke, -1

机译：EGFR介导的MAPK信号传导的重新激活有助于BRAF突变结直肠癌与vemureafenib的RAF抑制的不敏感性
7. RAF plus EGFR Inhibition for BRAF-Mutant Metastatic Colorectal Cancer—Response [O] . Rona Yaeger, Leonard B. Saltz 2015

机译：RAF加上EGFR抑制BRAF-突变转移性结直肠癌 - 反应

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

著录项

引文网络

相似文献

相关主题

期刊订阅